These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19867372)

  • 1. Immunoreactants in rheumatoid synovial effusions.
    Zvaifler NJ
    J Exp Med; 1971 Sep; 134(3):276-85. PubMed ID: 19867372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-derived leukotactic factors in inflammatory synovial fluids of humans.
    Ward PA; Zvaifler NJ
    J Clin Invest; 1971 Mar; 50(3):606-16. PubMed ID: 5545123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotactic activity for polymorphonuclear and mononuclear leukocytes in rheumatoid synovial fluids.
    Okamoto T; Ueda K; Kambara T; Kutsuna T
    Acta Pathol Jpn; 1986 Aug; 36(8):1109-22. PubMed ID: 3776528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG; McDuffie FC; Mullen BJ
    J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial fluid cells in Reiter's syndrome.
    Nordström D; Konttinen YT; Bergroth V; Leirisalo-Repo M
    Ann Rheum Dis; 1985 Dec; 44(12):852-6. PubMed ID: 3909972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    Hornum L; Hansen AJ; Tornehave D; Fjording MS; Colmenero P; Wätjen IF; Søe Nielsen NH; Bliddal H; Bartels EM
    PLoS One; 2017; 12(12):e0189017. PubMed ID: 29220376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of synovial fluid cryoprecipitates.
    Ludivico CL; Myers AR
    Ann Rheum Dis; 1980 Jun; 39(3):253-9. PubMed ID: 7416815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase.
    Jose PJ; Moss IK; Maini RN; Williams TJ
    Ann Rheum Dis; 1990 Oct; 49(10):747-52. PubMed ID: 2241262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
    Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
    Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin.
    Hasselbacher P
    Arthritis Rheum; 1979 Mar; 22(3):243-50. PubMed ID: 105740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
    Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
    J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
    Kazmierowski JA; Gallin JI; Reynolds HY
    J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
    Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
    Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyproline levels and collagenolytic activity in synovial fluids of patients with rheumatic diseases.
    Wize J; Sopata I; Gietka J; Jakubowski S; Kruze D
    Scand J Rheumatol; 1975; 4(2):65-72. PubMed ID: 1135610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural characteristics of synovial effusion cells in some arthropathies.
    Kapitonova MY; Othman M
    Malays J Pathol; 2004 Dec; 26(2):73-87. PubMed ID: 16329559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources.
    Bhardwaj N; Santhanam U; Lau LL; Tatter SB; Ghrayeb J; Rivelis M; Steinman RM; Sehgal PB; May LT
    J Immunol; 1989 Oct; 143(7):2153-9. PubMed ID: 2789256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.
    Stanczyk J; Kowalski ML; Grzegorczyk J; Szkudlinska B; Jarzebska M; Marciniak M; Synder M
    Mediators Inflamm; 2005 Dec; 2005(6):343-8. PubMed ID: 16489254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.